Tekla Healthcare Investor... (HQH)

Groundbreaking AI-powered initiatives are set to transform the healthcare landscape, potentially revolutionizing cancer research and healthcare investing. Aberdeen Investments' four healthcare-focused...

I maintain my buy rating on HQH for its high 13.6% yield, strong dividend coverage, and efficient healthcare sector diversification. HQH trades at an 8% discount to NAV, offering an attractive entry p...

HQH offers a compelling mix of high yield and growth exposure to healthcare, trading at a discount to NAV with recent outperformance versus benchmarks. The fund benefits from strong healthcare industr...

Berkshire Hathaway's portfolio of cash flow generators allows financial independence and opportunistic moves without financing dependencies. The "Income Method" aims to replicate Mr. Buffett's financi...

This month we got some increased market volatility, allowing me to put some of my cash pile to work in my closed-end fund portfolio. I also sold out of two positions, as they were starting to become o...